Sunstone Capital

DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.

BiotechDeep TechDigital HealthHealthtechMarseille, FR

Benjamin Charles(Co-Founder & CEO)Patrick Collombat(Co-Founder & Scientific Advisor)inJean-Pascal Tranié(Co-Founder)in

Co-investorsAdBio partnersRoche Venture FundBoehringer Ingelheim Venture FundJDRF T1D Fund

Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.

Digital HealthHealthtechMedical Devices

Co-investorsSEED Capital Denmark

Alligator Bioscience AB is a biotechnology company whose shares are listed on NASDAQ Stockholm (Small Cap) under the ticker ATORX.

BiotechHealthtechLund, SE

Mathias Uhlen(Director)Claes Ericsson(Director)Peter Benson(Director)Jacob Lindberg(Director)Kenth Petersson(Director)Jonas Sjogren(Director)

Arcoma develops high-end radiology and X-ray imaging systems, integrating detectors and imaging software through partnerships with technology providers such as Canon Medical Systems and Varex.

Advanced ManufacturingHardwareHealthtechMedical DevicesVäxjö, SE

Mattias Leire(VD (CEO))Mattias Guldstrand(CTO)Göran Edwall(Interim CFO)André Malmberg(COO)

Co-investorsEiffel Investment Group

Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs.

BiotechHealthtechMedical DevicesMalmö, SE

Magnus Corfitzen(Chief Executive Officer)Andreas Norlin(Chief Scientific Officer)Jennie Wilborgsson(Chief Operating Officer)Anton Hansson(Chief Financial Officer)

Co-investorsLumira Ventures

BiotechHealthtechMedical Devices

Co-investorsLongitude CapitalSGH Capital

BloomNation operates the Promenade SaaS platform, providing e-commerce, point-of-sale, and order management tools for local small businesses such as flower shops, restaurants, pizzerias, and beverage and liquor stores across the US.

ConsumerE-commerceMarketplacesRetail TechSaaS

Farbod Shoraka(CEO & Co-founder)Gregg Weisstein(Co-founder)

Co-investorsAndreessen HorowitzChicago VenturesSpark CapitalA.Capital VenturesLighter CapitalMucker Capital+5 more

Cantargia is a company listed on Nasdaq Stockholm (Small Cap).

BiotechHealthtech

Co-investorsBioMedPartnersInkef

Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products.

BiotechHealthtechMedical DevicesWayne, US

BARBARA A. CARLIN(SENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER)ROBERT S. RADIE(CHIEF EXECUTIVE OFFICER)MARK STROBECK(EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER)MEGAN TIMMINS(SENIOR VICE PRESIDENT AND GENERAL COUNSEL)PATRICK M. SHEA(SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER)Jeffrey M. Dayno(Chief Medical Officer)

Co-investorsAtlas Venture

Evolva (EvoNext Holdings SA / Evolva Holding AG) develops and markets flavour and fragrance products.

BiotechFoodTechNew Materials

Co-investorsVenturEastEntrepreneurs FundNice & Green

F2G is a biotechnology company developing novel antifungal therapies to treat rare, life-threatening fungal infections in defined patient populations.

BiotechHealthtech

Co-investorsAdvent Life SciencesAisling CapitalAMR Action FundAstellas Venture Management LLCBrace PharmaSofinnova Partners+3 more

Co-investorsInnovestor VenturesM Ventures

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

Jennifer Jarrett(Chief Executive Officer & Board Director)Sherwin Sattarzadeh(Chief Operating Officer)Becker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)Jim Baker(Chief Corporate Affairs Officer)Brian Burkavage(Senior Vice President, Finance)

Co-investorsEIR VenturesM VenturesSEED Capital DenmarkYsios CapitalMaverick VenturesOrbiMed

Grandhood provides pension advisory and financial services in Denmark.

FintechDenmark, DK

Erik Frandsen(Kaptajn & Ejer)Morten Dyhrberg Wewer(Co-CEO)Adam Ørskov(Co-CEO)

Co-investorsSEED Capital Denmark

The page presents a biography of Dr.

Biotech

Co-investorsAvoro Capital AdvisorsEIR VenturesKurma PartnersRA CapitalSamsara BioCapitalVivo Capital+2 more

Kynexis is a clinical-stage biotech developing KYN-5356, an oral small-molecule KAT-II inhibitor targeting the kynurenine pathway to improve cognition in neurological diseases.

BiotechDeep TechHealthtech

Robert Schwarcz(Scientific Co-founder)Carol Tamminga(Scientific Co-founder & Chair of the SAB)Christer Köhler(Founding Director)Kees Been(Chief Executive Officer)Jens Wendland(Chief Medical Officer)Neil Swami(Chief Business Officer)

Co-investorsYsios CapitalForbionNovartis Venture Fund

London, GB

Co-investorsTechstarsLifeline Ventures

MinervaX is a clinical-stage biotech company developing a prophylactic vaccine against Group B Streptococcus, with a lead candidate (AlpN GBS) in clinical trials for use in pregnancy and older adults.

BiotechHealthtech

Co-investorsAdjuvant CapitalIndustrifondenLU InnovationOrbiMedPureos BioventuresSanofi Ventures+1 more

Mojiworks develops games that connect communities through social play on platforms like Discord, Reddit, and Snapchat.

AI & Machine LearningCreator EconomyGaming

Matthew Wiggins(CEO)in

Co-investorsBalderton CapitalLifeline VenturesHeartcore Capital

Co-investorsIaso VenturesInvivo Capital Partners

Co-investorsIndustrifonden

Oblique Therapeutics is a biotechnology company developing new drug candidates, using its AbiProt technology to generate antibodies against high-value targets.

AI & Machine LearningBiotechStockholm, SE

Orphazyme was a biopharmaceutical company focused on research and development of therapeutics for neurodegenerative diseases such as Niemann Pick disease type C.

BiotechHealthtech

OxThera is a privately-held biopharmaceutical company developing Oxabact, an orally administered enteric biotherapy that promotes secretion and degradation of oxalate in the gut to reduce kidney burden.

BiotechHealthtechMedical DevicesStockholm, SE

Co-investorsYsios Capital

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.

BiotechHealthtechMedical DevicesCopenhagen, DK

Co-investorsCardinal PartnersM VenturesSeroba Life SciencesYsios Capital

Resalis Therapeutics develops RNA-based therapies targeting non-coding RNAs to address the underlying causes of complex metabolic disorders.

BiotechHealthtech

Co-investorsClaris VenturesItalian Angels for Growth

Biopharmaceutical company targeting RIG-I for immune-mediated treatment of cancer and viral diseases; acquired by Merck in 2017.

Co-investorsMC Healthcare Ventures

Rewind Therapeutics is a biotech company developing first-in-class remyelination therapeutics that aim to repair the myelin sheath in patients with diseases such as multiple sclerosis, optic neuritis, and nerve injuries.

BiotechDeep TechHealthtechLeuven, BE

Co-investorsBoehringer Ingelheim Venture FundPMVM Ventures

Step Pharma develops dencatistat (STP938), a first-in-class, orally bioavailable CTPS1 inhibitor in clinical development as a targeted oncology therapy for blood cancers such as lymphoma and essential thrombocythaemia as well as solid tumours including ovarian cancer.

BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR

Co-investorsHadean VenturesKurma PartnersPontifax Venture CapitalV-Bio Ventures

Synendos Therapeutics is a clinical-stage neuroscience company developing therapies that target the Endocannabinoid System to treat neuropsychiatric disorders at their root cause.

BiotechDeep TechMental Health

Co-investorsKurma PartnersYsios Capital

TargED Biopharmaceuticals is a Netherlands-based biotechnology company developing first-in-class biological drugs that use small antibodies (VHH) to deliver enzymes to sites of thrombosis for targeted thrombolysis.

BiotechMedical Devices

Co-investorsAndera PartnersCurie CapitalFund+Hadean VenturesRotripBioGeneration Ventures+1 more

Teitur Trophics is a biotech company developing first-in-class cyclic peptides that target lysosomal, mitochondrial and pro-survival signaling pathways to preserve neuronal function.

BiotechDeep TechHealthtechAarhus, DK

Simon Mølgaard(Co-founder & CEO)Anders Dalby(Co-founder)Mathias Ollendorff(Co-founder)Simon Glerup(Co-founder)

Co-investorsIndustrifondenP53 InvestInnovestorSound Bioventures

Tink operates a cloud-based open banking platform accessed through a single API, offering payment initiation and account data aggregation/enrichment services under its own PSD2 license.

Data & InfrastructureFintechSaaS

Daniel Kjellén(Founder)in

Co-investorsDawn CapitalFinTech VenturesInsight PartnersOpera Tech Ventures

VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego.

BiotechDigital HealthHealthtech

Andreas Niethammer(Founder & Chief Executive Officer)

Co-investorsAvoro Capital AdvisorsKurma PartnersOberland Capital

Zolar operates an online platform that connects homeowners in Germany with vetted regional installation companies for solar and clean-energy projects, including photovoltaic systems, balcony power plants, wallboxes, and solar storage.

CleantechEnergyMarketplaces

Alex Melzer(Founder)in

Co-investorsEnergy Impact PartnersInven CapitalBNP ParibasStatkraft Ventures